FDA Yanks Ozone-Depleting Inhaler From Market

Law360, New York (September 22, 2011, 3:24 PM EDT) -- The U.S. Food and Drug Administration announced Thursday it was taking the only agency-approved over-the-counter asthma inhaler off the market at the end of the year because it uses a compound that harms the ozone layer.

Primatene Mist, an epinephrine inhaler manufactured by Armstrong Pharmaceuticals Inc., will not be made or sold after Dec. 31, the FDA said. The product uses chlorofluorocarbons, or CFCs, to propel an asthma-relief medication out of the inhaler into a user's lungs.

The agency said it made the move in order...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.